These include gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation), injection site reactions, and, rarely, pancreatitis (severe upper abdominal pain radiating to the back) or gallbladder problems
Clinically, SGLT2 inhibitors have demonstrated cardiovascular benefit in patients with atherosclerotic cardiovascular disease and T2DM, making them a first-line therapeutic approach for this group of patients 44
Accordingly, the metabolic consequences of GLP-1RA therapy cannot be inferred solely from improvements in inflammatory tone or glycemic control
Not only does NAC alone not appear to help muscle protein synthesis or nitric oxide metabolism like Setria Performance Blend was hoped to, some studies also suggest that NAC may inhibit the body's nitric oxide production by interfering with the absorption of nitrite in the kidneys